They also demonstrate advantages in areas such as weight loss, improved cardiovascular health, reduced risk of cardiovascular events, and potential cognitive benefits
Al-Ayadhi LY
GLP-1s can also reduce inflammation by suppressing NF-B which is crucial in order to recruit inflammatory cells to sites of inflammation [2]
As with other GLP-1s, gastrointestinal adverse events (nausea, constipation, diarrhea and vomiting) were the most common but were typically mild-to-moderate
Many patients achieve significant and lasting weight loss when these medications are combined with lifestyle changes
Instead of focusing only on calorie restriction, modern research increasingly explores: Hormonal appetite regulation Gut-brain signalling Insulin sensitivity Energy expenditure Body composition Cardiometabolic risk markers This is why Retatrutide is often mentioned in the same conversation as GLP-1 receptor agonists, GIP/GLP-1 dual agonists, and other next-generation metabolic peptides